These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11460038)

  • 21. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.
    Schmit I; Boivin G
    J Infect Dis; 1999 Aug; 180(2):487-90. PubMed ID: 10395866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of cutaneous human papilloma virus, poxvirus and herpes simplex virus infections with topical cidofovir in HIV positive patients].
    Toutous-Trellu L; Hirschel B; Piguet V; Schiffer V; Saurat JH; Pechère M
    Ann Dermatol Venereol; 2004 May; 131(5):445-9. PubMed ID: 15235531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation.
    Voigt S; Hofmann J; Edelmann A; Sauerbrei A; Kühl JS
    Transpl Infect Dis; 2016 Oct; 18(5):791-794. PubMed ID: 27482652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options.
    Reusser P
    J Hosp Infect; 1996 Aug; 33(4):235-48. PubMed ID: 8864937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful treatment of acyclovir-resistant herpes simplex virus with intralesional cidofovir.
    Castelo-Soccio L; Bernardin R; Stern J; Goldstein SA; Kovarik C
    Arch Dermatol; 2010 Feb; 146(2):124-6. PubMed ID: 20157021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic hypertrophic acyclovir-resistant genital herpes treated with topical cidofovir and with topical foscarnet at recurrence in an HIV-positive man.
    Ghislanzoni M; Cusini M; Zerboni R; Alessi E
    J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):887-9. PubMed ID: 16898926
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of Azone upon the in vivo antiviral efficacy of cidofovir or acyclovir topical formulations in treatment/prevention of cutaneous HSV-1 infections and its correlation with skin target site free drug concentration in hairless mice.
    Afouna MI; Fincher TK; Zaghloul AA; Reddy IK
    Int J Pharm; 2003 Mar; 253(1-2):159-68. PubMed ID: 12593946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel resistance-associated mutations of thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 and type 2.
    Sauerbrei A; Bohn K; Heim A; Hofmann J; Weissbrich B; Schnitzler P; Hoffmann D; Zell R; Jahn G; Wutzler P; Hamprecht K
    Antivir Ther; 2011; 16(8):1297-308. PubMed ID: 22155911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous herpes simplex virus infection of the guinea pig: lack of resistance to acyclovir and phosphonoformic acid after topical treatment.
    Poryo A; Wigand R
    Med Microbiol Immunol; 1984; 173(4):219-24. PubMed ID: 6096685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical Treatment of Acyclovir-Resistant Herpes Simplex Virus Stomatitis after Allogeneic Hematopoietic Cell Transplantation.
    Heidenreich D; Kreil S; Mueller N; Jawhar M; Nolte F; Hofmann WK; Klein SA
    Oncol Res Treat; 2020; 43(12):672-678. PubMed ID: 33070144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of the treatment protocol upon the in vivo efficacy of cidofovir (HPMPC) and of acyclovir (ACV) formulations in topical treatment of cutaneous HSV-1 infection in hairless mice.
    Afouna MI; Mehta SC; Ghanem AH; Higuchi WI; Kern ER; DeClercq E; El-Shattawy HH
    J Pharm Sci; 1999 May; 88(5):530-4. PubMed ID: 10229644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acyclovir-resistant perineal HSV infection revealing chronic lymphoid leukaemia].
    Casassa EA; Nicol P; Viraben R; Gaudin C; Bulai Livideanu C; Mengelle C; Lamant L; Fortenfant F; Paul C; Konstantinou MP
    Ann Dermatol Venereol; 2018 Mar; 145(3):182-186. PubMed ID: 29221652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brincidofovir treatment of acyclovir-resistant disseminated varicella zoster virus infection in an immunocompromised host.
    Mullane KM; Nuss C; Ridgeway J; Prichard MN; Hartline CB; Theusch J; Mommeja-Marin H; Larson RA
    Transpl Infect Dis; 2016 Oct; 18(5):785-790. PubMed ID: 27481400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acyclovir-resistant herpes: expanded access available for cidofovir gel (Forvade).
    AIDS Treat News; 1997 Feb; (No 264):5. PubMed ID: 11364104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful foscarnet therapy for acyclovir-resistant mucocutaneous infection with herpes simplex virus in a recipient of allogeneic BMT.
    Verdonck LF; Cornelissen JJ; Smit J; Lepoutre J; de Gast GC; Dekker AW; Rozenberg-Arska M
    Bone Marrow Transplant; 1993 Feb; 11(2):177-9. PubMed ID: 8382096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of acyclovir-resistant herpes simplex virus infections in patients with AIDS.
    Safrin S
    J Acquir Immune Defic Syndr (1988); 1992; 5 Suppl 1():S29-32. PubMed ID: 1602361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral topical cidofovir: novel route of drug delivery in a severely immunosuppressed patient with refractory multidrug-resistant herpes simplex virus infection.
    Sims CR; Thompson K; Chemaly RF; Shpall EJ; Champlin RE; Safdar A
    Transpl Infect Dis; 2007 Sep; 9(3):256-9. PubMed ID: 17605730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-resistant herpes simplex virus in HIV infected patients.
    Lolis MS; González L; Cohen PJ; Schwartz RA
    Acta Dermatovenerol Croat; 2008; 16(4):204-8. PubMed ID: 19111144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acyclovir-resistant, foscarnet-sensitive oral herpes simplex type 2 lesion in a patient with AIDS.
    MacPhail LA; Greenspan D; Schiødt M; Drennan DP; Mills J
    Oral Surg Oral Med Oral Pathol; 1989 Apr; 67(4):427-32. PubMed ID: 2524706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limited efficacy of inhibitors of herpes simplex virus DNA synthesis in murine models of recrudescent disease.
    Kristofferson A; Ericson AC; Sohl-Akerlund A; Datema R
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1157-66. PubMed ID: 2838569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.